iShares Genomics Immunology and Healthcare ETF
ETFYour view on IDNA
iShares Genomics Immunology and Healthcare ETF
ETFISharesSentiment
AUM (USD)
$197.81M
Expense Ratio
0.47%
Holdings
50
Sentiment
Overview for iShares Genomics Immunology and Healthcare ETF
- Fund Type
- ETF
- Fund Issuer
- IShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- June 11, 2019
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- IShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- June 11, 2019
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- IShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- June 11, 2019
- Domicile
- US
About this fund
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
IDNA Stock Price
Key Facts
EquityExpense Ratio
0.47%
AUM
$197.81M
Fund Details
Expense Ratio
0.47%
Assets Under Management
$197.81M
NAV
$33.53 USD
Holdings
50
Average Volume
51.5K
Inception Date
June 11, 2019
Asset Class
Equity
Fund Issuer
IShares
Domicile
US
ISIN
US46435U1925
CUSIP
46435U192
NAV Currency
USD
Expense Ratio
0.47%
Assets Under Management
$197.81M
NAV
$33.53 USD
Holdings
50
Average Volume
51.5K
Inception Date
June 11, 2019
Asset Class
Equity
Fund Issuer
IShares
Domicile
US
ISIN
US46435U1925
CUSIP
46435U192
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.